Page last updated: 2024-10-29

ketamine and Glaucoma, Angle Closure

ketamine has been researched along with Glaucoma, Angle Closure in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
"Senile glaucoma is a common ophthalmological disease in the elderly."1.72Explore the molecular mechanism of angle-closure glaucoma in elderly patients induced telomere shortening of retinal ganglion cells through oxidative stress. ( Chen, F; Xia, X; Yan, A; Zhou, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhou, J1
Chen, F1
Yan, A1
Xia, X1

Other Studies

1 other study available for ketamine and Glaucoma, Angle Closure

ArticleYear
Explore the molecular mechanism of angle-closure glaucoma in elderly patients induced telomere shortening of retinal ganglion cells through oxidative stress.
    Nucleosides, nucleotides & nucleic acids, 2022, Volume: 41, Issue:10

    Topics: Animals; beta-Galactosidase; Disease Models, Animal; Fluorescent Dyes; Glaucoma; Glaucoma, Angle-Clo

2022